Literature DB >> 16970843

Evaluation of the influence of antiepileptic therapy on antioxidant enzyme activity and lipid peroxidation in erythrocytes of children with epilepsy.

Wojciech Sobaniec1, Elzbieta Solowiej, Wojciech Kulak, Leszek Bockowski, Joanna Smigielska-Kuzia, Barbara Artemowicz.   

Abstract

The aim of this study was to evaluate the influence of antiepileptic therapy on antioxidant enzyme activity and lipid peroxidation in the erythrocytes of children with epilepsy. For this purpose, the activity of superoxide dismutase, glutathione peroxidase, and glutathione reductase and the malondialdehyde concentration in 61 healthy children and 90 children with epilepsy were measured. The activities of all of these enzymes were insignificantly higher, whereas the malondialdehyde concentration was significantly lower in the patients treated with carbamazepine monotherapy. In patients treated with valproate monotherapy, the activities of all enzymes were insignificantly lower, whereas the malondialdehyde concentration was insignificantly higher. In patients treated with polytherapy, the activity of superoxide dismutase was insignificantly lower, whereas the activity of glutathione peroxidase and glutathione reductase was insignificantly higher and the malondialdehyde concentration was lower. There were differences in glutathione reductase activity between the valproate monotherapy group and both the carbamazepine monotherapy and polytherapy groups and in malondialdehyde concentrations between the carbamazepine and valproate groups. The results indicate that the oxidant-antioxidant balance in children with epilepsy is modified by antiepileptic therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16970843     DOI: 10.1177/08830738060210070501

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  7 in total

1.  Outcome measures in pediatric polypharmacy research: a scoping review.

Authors:  Negar Golchin; Hannah Johnson; Paul M Bakaki; Neal Dawson; Elia M Pestana Knight; Sharon B Meropol; Rujia Liu; James A Feinstein; Shari D Bolen; Lawrence C Kleinman; Alexis Horace
Journal:  Drugs Ther Perspect       Date:  2019-07-12

2.  Antioxidants as a preventive treatment for epileptic process: a review of the current status.

Authors:  Boštjan Martinc; Iztok Grabnar; Tomaž Vovk
Journal:  Curr Neuropharmacol       Date:  2014-12       Impact factor: 7.363

Review 3.  Modulation of antioxidant enzymatic activities by certain antiepileptic drugs (valproic acid, oxcarbazepine, and topiramate): evidence in humans and experimental models.

Authors:  Noemí Cárdenas-Rodríguez; Elvia Coballase-Urrutia; Liliana Rivera-Espinosa; Arantxa Romero-Toledo; Aristides Sampieri; Daniel Ortega-Cuellar; Hortencia Montesinos-Correa; Esaú Floriano-Sánchez; Liliana Carmona-Aparicio
Journal:  Oxid Med Cell Longev       Date:  2013-12-17       Impact factor: 6.543

4.  Effect of saffron (Crocus sativus L.) on sodium valporate induced cytogenetic and testicular alterations in albino rats.

Authors:  Saber A Sakr; Mohamed E Zowail; Amera M Marzouk
Journal:  Anat Cell Biol       Date:  2014-09-23

5.  Evaluation of selenium levels and mean platelet volume in patients with simple febrile convulsion.

Authors:  Mahmut Abuhandan; Abdullah Solmaz; Suleyman Geter; Cemil Kaya; Bulent Guzel; Ilhan Yetkin; Bulent Koca
Journal:  Iran J Pediatr       Date:  2014-07-02       Impact factor: 0.364

6.  The role of Mean Platelet Volume/platelet count Ratio and Neutrophil to Lymphocyte Ratio on the risk of Febrile Seizure.

Authors:  Zhigang Liu; Xiangxin Li; Meipin Zhang; Xiaofei Huang; Jun Bai; Zhiwei Pan; Xiuxian Lin; Dongni Yu; Huaping Zeng; Ruiping Wan; Xingguang Ye
Journal:  Sci Rep       Date:  2018-10-11       Impact factor: 4.379

7.  The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress.

Authors:  Boštjan Martinc; Iztok Grabnar; Tomaž Vovk
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.